NTRK1 and mastocytosis: Although the precise impact of NGF and its receptors on mastocytosis pathogenesis is not entirely clear, murine models have shown that TrkA activation leads to mastocytosis and is involved in the development of resistance to the receptor tyrosine kinase KIT-targeted therapy, which targets the mast/stem cell growth factor receptor KIT.